Network Bio has entered into a research collaboration with Duke University to develop AI models of human disease using biospecimens...
OncoC4 has reported positive findings from Phase I/II trials of its investigational bispecific antibody, cesalatamig, as a monotherapy in patients...
Lighthouse Two will subscribe for shares representing 16.7% of LifeTech's share capital.The post GL Capital and Zylox-Tonbridge to invest $189m...
GeneDx and Mirum Pharmaceuticals have partnered to provide no-cost exome sequencing for eligible patients across cholestasis, early-onset cataracts, and PBD-ZSD...
Mondego Bio has started a first-in-human Phase Ia clinical trial of MB 388, which is designed to act in both...
Alfasigma has received the EC's expanded approval for Jyseleca to treat adult patients living with active axial spondyloarthritis (axSpA).The post...
Laza Medical has secured up to $160m in a Series B structured financing round to advance robotic imaging technology for...
Tango Therapeutics and Erasca have begun enrolment for a Phase I/II trial assessing the combination of oral therapies ERAS-0015 and...
PharmatrophiX and Circular Genomics have partnered to advance blood-based circular RNA biomarkers in neurodegenerative drug development programmes.The post PharmatrophiX and...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.